US Stock MarketDetailed Quotes

GNLX Genelux

Watchlist
  • 3.635
  • +0.115+3.27%
Trading Apr 17 15:26 ET
97.66MMarket Cap-3442P/E (TTM)

About Genelux Company

Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.

Company Profile

SymbolGNLX
Company NameGenelux
Listing DateJan 26, 2023
Issue Price6.00
Founded2001
CEOMr. Thomas Zindrick, J.D.
MarketNASDAQ
Employees23
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2625 Townsgate Road,Suite 230
CityWestlake Village
ProvinceCalifornia
CountryUnited States of America
Zip Code91361
Phone1-858-267-9889

Company Executives

  • Name
  • Position
  • Salary
  • Thomas Zindrick, J.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 500.00K
  • Lourie S. Zak
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Paul Scigalla, M.D.
  • Chief Medical Officer
  • --
  • Dr. Joseph Cappello, PhD
  • Chief Technical Officer
  • --
  • Dr. Tony Yu, PhD
  • Senior Vice President, Clinical Development
  • --
  • Dr. John Thomas, PhD
  • Director
  • 233.62K
  • Mary Mirabelli
  • Director
  • 233.62K
  • John W. Smither
  • Independent Director
  • --
  • James L. Tyree
  • Lead Independent Director
  • 233.62K
  • Sean Ryder, J.D.
  • General Counsel and Corporate Secretary
  • 380.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg